LMNX News and Press, Luminex Corporation From 01/14/21

Roubaix Capital, LLC provides investment advisory services. The Company offers investment and portfolio management services for pooled investment vehicles. Roubaix Capital serves customers in the U.S. During the fourth quarter of 2020, the Roubaix Fund Composite gained 26.63% on a net...

GenMark is in the early stages of an accelerated growth phase, backed by the cadence of ePlex instillations, having benefitted from a large Covid-19 tailwind. Management are solid on scaling production to 250K ePlex units by Q3 2021 and are aiming to reach 60% gross profit margins ove...

Luminex Corporation (LMNX) expects Q4 revenue of ~$111M (~+23% Y/Y) vs. consensus of $104.6M and FY2020 revenue of ~$417M (~+25% Y/Y) vs. consensus of $410.6M.For FY2020, total molecular diagnostics (MDx) revenue to be $228M vs. $137M in FY2019; Licensed Technologies Group revenue of ~$1...

Luminex Corporation Pre-Release of 4th Quarter 2020 Revenue Fourth Quarter Earnings Call Scheduled for February 8, 2021 PR Newswire AUSTIN, Texas , Jan. 12, 2021 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced 4 th quarter 2020...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference AUSTIN, Texas , Dec. 16, 2020 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that Nachum "Homi" Shamir, Chairman, CEO and President, and Harriss Currie , Senior ...

Luminex (LMNX) declares $0.10/share quarterly dividend, 11.1% increase from prior dividend of $0.09.Forward yield 1.67%Payable Jan. 14; for shareholders of record Dec. 23; ex-div Dec. 22.See LMNX Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Luminex in...

Luminex has had a volatile year that reflects FDA headwinds and a rotation out of Covid-19 exposure. Management had baked Covid-19 related sales into previous modelling but have downgraded FY2020 guidance by ~$5 million. FY 2021 growth of ~15% is now guided, but we need more evide...

The FDA has issued an emergency use authorization ((EUA)) to the single-use COVID-19 diagnostic test kit from Lucira Health, a California manufacturer.The Lucira COVID-19 All-In-One at home test kit provides rapid results. To date, the Agency has authorized nearly 300 test...

Testing, testing... One, two. Three, four."Something extremely bogus is going on. Was tested for covid four times today. Two tests came back negative, two came back positive. Same machine, same test, same nurse. Rapid antigen test from BD," Elon Musk wrote on Twitter, possibly referring to Be...